No Data
No Data
Press Release: Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2024 Financial Results
Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2024 Financial Results LOS ANGELES--(BUSINESS WIRE)--July 18, 2024-- Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical
Puma Seems Ready to Return to Growth -- Market Talk
1153 GMT - Puma should see improved momentum in the second quarter and return to earnings growth, Warburg analyst Joerg Philipp Frey writes in a research note. The German sporting-goods company posted
Puma Biotechnology(PBYI.US) Officer Sells US$17,306.71 in Common Stock
$Puma Biotechnology(PBYI.US)$ Officer NOUGUES MAXIMO F sold 5,295 shares of common stock on Jul 2, 2024 at an average price of $3.2685 for a total value of $17,306.71.Source: Announcement What is stat
Puma Biotechnology(PBYI.US) Officer Sells US$19,777.69 in Common Stock
$Puma Biotechnology(PBYI.US)$ Officer Ludwig Jeffrey Jerome sold 6,051 shares of common stock on Jul 2, 2024 at an average price of $3.2685 for a total value of $19,777.69.Source: Announcement What is
Puma Biotechnology(PBYI.US) Officer Sells US$14,214.71 in Common Stock
$Puma Biotechnology(PBYI.US)$ Officer HUNT DOUGLAS M sold 4,349 shares of common stock on Jul 2, 2024 at an average price of $3.2685 for a total value of $14,214.71.Source: Announcement What is statem
Puma Biotechnology(PBYI.US) 10% Shareholder Sells US$61,725.62 in Common Stock
$Puma Biotechnology(PBYI.US)$ 10% Shareholder AUERBACH ALAN H sold 18,885 shares of common stock on Jul 2, 2024 at an average price of $3.2685 for a total value of $61,725.62.Source: Announcement What
No Data
Stoic Trader : There was big buyers 2 weeks ago I am still watching looks good run >100%s still left currently no position out of bullet